Anthony S. Fiorino's Net Worth
-$27.9 Thousand
Who is Anthony S. Fiorino?
Anthony S. Fiorino does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NAVIDEA BIOPHARMACEUTICALS, INC., BRAINSTORM CELL THERAPEUTICS INC., and IMMUNE PHARMACEUTICALS INC.
SEC CIK
Anthony S. Fiorino's CIK is 0001608901
Past Insider Trading and Trends
2014 was Anthony S. Fiorino's most active year for acquiring shares with 8 total transactions. Anthony S. Fiorino's most active month to acquire stocks was the month of August. 2020 was Anthony S. Fiorino's most active year for disposing of shares, totalling 1 transactions. Anthony S. Fiorino's most active month to dispose stocks was the month of January. 2018 saw Anthony S. Fiorino paying a total of $18,877.50 for 75,000 shares, this is the most they've acquired in one year. In 2020 Anthony S. Fiorino cashed out on 75,000 shares for a total of $262.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Snapshot price: $0.0251
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.2803
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.00% | 500 |
$3.60 | $1,797.70 | 2.5K |
Oct 15
| |||
Form 4
| +66.67% | 800 |
$3.84 | $3,072.00 | 2K |
Sep 18
| |||
Form 4
|
∞
| 18K |
$0.28 | $5,125.50 | 18K |
Sep 12 - Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMMUNE PHARMACEUTICALS INC No price found
Chief Medical Officer and COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -75.00K |
—
| -$262.50 |
0
|
Feb 3
| |||
Form 4
| +50.00% | 25K |
$0.24 | $5,977.50 | 75K |
May 22
| |||
Form 4
|
∞
| 50K |
$0.26 | $12,900.00 | 50K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||